首页 > 最新文献

Biomarkers in medicine最新文献

英文 中文
Systemic immune-inflammation index as a biomarker for stroke prognosis: insights from a multi-time point analysis. 全身免疫炎症指数作为脑卒中预后的生物标志物:来自多时间点分析的见解。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-08-08 DOI: 10.1080/17520363.2025.2540760
Yanan Wang, Jiaojiao Wang, Fengmei Tian, Mengyun Peng, Xiaomin Ma, Dahong Zheng, Xiaoxiao Li, Jingya Jiao, Liping Zheng, Zhengbao Zhu, Shu Ji, Daoxia Guo

Aims: This study aimed to investigate the association between the systemic immune-inflammation index (SII) and prognosis trajectories in ischemic stroke(IS).

Methods: Patients from two tertiary hospitals in Suzhou were included in this study. SII was calculated as neutrophils×platelets/lymphocytes, and patients were categorized into quartiles based on SII values. Latent class growth modeling (LCGM) was employed to describe the trajectories of modified Rankin Scale (mRS) at different time points.Logistic regression models were used to evaluate the association between SII quartiles and prognosis trajectories at multiple time points (14 days, 1 month, 3 months, 6 months)and prognostic trajectories.

Results: Patients in the highest quartile (Q4) of SII had a significantly higher risk of adverse outcomes compared to those in the lowest quartile (Q1). A three-group model was identified as the optimal trajectory model for stroke prognosis. SII was associated with 4.06-fold increased odds (95% CI: 1.64-10.08) of unfavorable prognosis trajectories. Per standard deviation increase in the logarithmic SII, the odds of unfavorable prognosis trajectories were 1.64 (95% CI: 1.18-2.29).

Conclusions: Baseline SII is significantly associated with unfavorable outcome trajectories across multiple time points in IS. These findings highlight the potential value of SII as a predictive biomarker for sequential prognosis in stroke patients.

目的:本研究旨在探讨缺血性脑卒中(IS)患者全身免疫炎症指数(SII)与预后轨迹的关系。方法:选取苏州市两所三级医院的患者为研究对象。SII计算为neutrophils×platelets/淋巴细胞,并根据SII值将患者分为四分位数。采用潜在类别增长模型(LCGM)描述修正Rankin量表(mRS)在不同时间点的轨迹。采用Logistic回归模型评估SII四分位数与预后轨迹在多个时间点(14天、1个月、3个月、6个月)和预后轨迹之间的关系。结果:SII最高四分位数(Q4)的患者发生不良结局的风险明显高于最低四分位数(Q1)的患者。三组模型是脑卒中预后的最佳轨迹模型。SII与不良预后轨迹的几率增加4.06倍相关(95% CI: 1.64-10.08)。对数SII每增加一个标准差,出现不良预后轨迹的几率为1.64 (95% CI: 1.18-2.29)。结论:在is的多个时间点上,基线SII与不利的结局轨迹显著相关。这些发现突出了SII作为脑卒中患者序贯预后预测生物标志物的潜在价值。
{"title":"Systemic immune-inflammation index as a biomarker for stroke prognosis: insights from a multi-time point analysis.","authors":"Yanan Wang, Jiaojiao Wang, Fengmei Tian, Mengyun Peng, Xiaomin Ma, Dahong Zheng, Xiaoxiao Li, Jingya Jiao, Liping Zheng, Zhengbao Zhu, Shu Ji, Daoxia Guo","doi":"10.1080/17520363.2025.2540760","DOIUrl":"10.1080/17520363.2025.2540760","url":null,"abstract":"<p><strong>Aims: </strong>This study aimed to investigate the association between the systemic immune-inflammation index (SII) and prognosis trajectories in ischemic stroke(IS).</p><p><strong>Methods: </strong>Patients from two tertiary hospitals in Suzhou were included in this study. SII was calculated as neutrophils×platelets/lymphocytes, and patients were categorized into quartiles based on SII values. Latent class growth modeling (LCGM) was employed to describe the trajectories of modified Rankin Scale (mRS) at different time points.Logistic regression models were used to evaluate the association between SII quartiles and prognosis trajectories at multiple time points (14 days, 1 month, 3 months, 6 months)and prognostic trajectories.</p><p><strong>Results: </strong>Patients in the highest quartile (Q4) of SII had a significantly higher risk of adverse outcomes compared to those in the lowest quartile (Q1). A three-group model was identified as the optimal trajectory model for stroke prognosis. SII was associated with 4.06-fold increased odds (95% CI: 1.64-10.08) of unfavorable prognosis trajectories. Per standard deviation increase in the logarithmic SII, the odds of unfavorable prognosis trajectories were 1.64 (95% CI: 1.18-2.29).</p><p><strong>Conclusions: </strong>Baseline SII is significantly associated with unfavorable outcome trajectories across multiple time points in IS. These findings highlight the potential value of SII as a predictive biomarker for sequential prognosis in stroke patients.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"697-705"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144798226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of lnc-RNAs TINCR, GC1 and AFAP1-AS1 in gastric cancer differentiation from healthy people. lnc- rna TINCR、GC1和AFAP1-AS1在健康人胃癌分化中的诊断价值。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-08-05 DOI: 10.1080/17520363.2025.2542112
Pouneh Pourfarzam, Mohammad Bagher Khademerfan, Ramin Shakeri, Reza Ghanbari, Asaad Azarnezhad

Aims and background: Gastric cancer is a significant health challenge globally, necessitating the identification of novel biomarkers for improved diagnosis. Our study aimed to address this gap by investigating the diagnostic potential a set of long non-coding RNAs (lncRNAs) in gastric cancer patients compared to healthy controls.

Materials and methods: We conducted a retrospective case-control analysis involving 256 participants, including 128 gastric cancer patients and 128 healthy individuals. Alongside the measurement of serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19.9), the plasma expression profiling of eight lnc-RNAs was performed in the selected samples.

Results: Our findings revealed significant alterations in CEA and CA19.9 levels in gastric cancer patients compared to controls (p < 0.05). Moreover, upregulated expression of lncRNAs, including HOTIP, BANCR, ZFAS1, TINCR, GC1, and AFAP1-AS1, were all observed in gastric cancer patients (p < 0.05). Excluding lncUGC1 and FAM49B-AS, ROC curve analysis demonstrated the diagnostic potential of lncRNAs in gastric cancer detection, with notable specificity and sensitivity.

Conclusion: Our study disclosed the diagnostic utility of plasma HOTIP, BANCR, ZFAS1, TINCR, GC1, and AFAP1-AS1 lncRNAs as appropriate diagnostic biomarkers for gastric cancer. The identification of dysregulated lncRNAs offers promising avenues for noninvasive diagnostic assessment in gastric cancer.

目的和背景:胃癌是全球性的重大健康挑战,需要鉴定新的生物标志物来改善诊断。我们的研究旨在通过研究一组长链非编码rna (lncRNAs)在胃癌患者中与健康对照组相比的诊断潜力来解决这一空白。材料与方法:采用回顾性病例对照分析,共纳入256例受试者,其中胃癌患者128例,健康人128例。在测定血清癌胚抗原(CEA)和碳水化合物抗原19-9 (CA19.9)水平的同时,对所选样本进行8种lnc- rna的血浆表达谱分析。结论:我们的研究揭示了血浆HOTIP、BANCR、ZFAS1、TINCR、GC1和AFAP1-AS1 lncRNAs作为胃癌诊断的合适生物标志物的诊断价值。失调lncrna的鉴定为胃癌的无创诊断评估提供了有希望的途径。
{"title":"Diagnostic value of lnc-RNAs TINCR, GC1 and AFAP1-AS1 in gastric cancer differentiation from healthy people.","authors":"Pouneh Pourfarzam, Mohammad Bagher Khademerfan, Ramin Shakeri, Reza Ghanbari, Asaad Azarnezhad","doi":"10.1080/17520363.2025.2542112","DOIUrl":"10.1080/17520363.2025.2542112","url":null,"abstract":"<p><strong>Aims and background: </strong>Gastric cancer is a significant health challenge globally, necessitating the identification of novel biomarkers for improved diagnosis. Our study aimed to address this gap by investigating the diagnostic potential a set of long non-coding RNAs (lncRNAs) in gastric cancer patients compared to healthy controls.</p><p><strong>Materials and methods: </strong>We conducted a retrospective case-control analysis involving 256 participants, including 128 gastric cancer patients and 128 healthy individuals. Alongside the measurement of serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19.9), the plasma expression profiling of eight lnc-RNAs was performed in the selected samples.</p><p><strong>Results: </strong>Our findings revealed significant alterations in CEA and CA19.9 levels in gastric cancer patients compared to controls (<i>p</i> < 0.05). Moreover, upregulated expression of lncRNAs, including HOTIP, BANCR, ZFAS1, TINCR, GC1, and AFAP1-AS1, were all observed in gastric cancer patients (<i>p</i> < 0.05). Excluding lncUGC1 and FAM49B-AS, ROC curve analysis demonstrated the diagnostic potential of lncRNAs in gastric cancer detection, with notable specificity and sensitivity.</p><p><strong>Conclusion: </strong>Our study disclosed the diagnostic utility of plasma HOTIP, BANCR, ZFAS1, TINCR, GC1, and AFAP1-AS1 lncRNAs as appropriate diagnostic biomarkers for gastric cancer. The identification of dysregulated lncRNAs offers promising avenues for noninvasive diagnostic assessment in gastric cancer.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"757-767"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144783554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between red cell distribution width-to-albumin ratio and In-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: a retrospective cohort study. 慢性阻塞性肺疾病急性加重和呼吸衰竭患者的红细胞分布宽度与白蛋白比与住院死亡率的关系:一项回顾性队列研究
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-08-19 DOI: 10.1080/17520363.2025.2548189
Ruoqing Zhou, Dianzhu Pan

Aims: This study aimed to investigate the association between the Red cell distribution width-to-albumin ratio (RAR) and in-hospital mortality in patients experiencing Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) with concurrent Respiratory Failure (RF).

Methods: This retrospective study included 594 patients diagnosed with AECOPD and RF at the first affiliated hospital of Jinzhou Medical University, China, between January 2021 and September 2023. The primary outcome measure was in-hospital mortality rate. The participants were categorized into three groups according to RAR tertiles: T1 (2.535-3.871), N = 198; T2 (3.88-4.547), N = 196; and T3 (4.56-11.031), N = 200. Logistic regression and subgroup analyses were performed to investigate the relationship between RAR and AECOPD and RF prognosis in patients.

Results: The average age of the participants was 72.1 ± 9.7 years, with 52.2% men (n = 310). The mean RAR was 4.3 ± 1.0%/g/dL. After adjusting for covariates, the odds ratio for in-hospital mortality per unit increase in RAR was 1.74 [95% Confidence Interval: 1.19-2.55], p = 0.004. A linear relationship was observed between RAR and in-hospital mortality among patients with AECOPD and RF.

Conclusion: RAR is an independent risk factor for in-hospital mortality in patients with AECOPD complicated by RF. Elevated RAR levels were associated with increased in-hospital mortality in our patient cohort.

目的:本研究旨在探讨慢性阻塞性肺疾病急性加重期(AECOPD)并发呼吸衰竭(RF)患者的红细胞分布宽度与白蛋白比(RAR)与住院死亡率之间的关系。方法:本回顾性研究纳入2021年1月至2023年9月在中国锦州医科大学第一附属医院诊断为AECOPD和RF的594例患者。主要结局指标为住院死亡率。根据RAR值将参与者分为3组:T1 (2.535 ~ 3.871), N = 198;T2 (3.88-4.547), n = 196;T3 (4.56 ~ 11.031), N = 200。采用Logistic回归和亚组分析探讨RAR和AECOPD与患者RF预后的关系。结果:参与者的平均年龄为72.1±9.7岁,男性占52.2% (n = 310)。平均RAR为4.3±1.0%/g/dL。调整协变量后,RAR每单位增加的住院死亡率的优势比为1.74[95%置信区间:1.19-2.55],p = 0.004。在AECOPD和RF患者中,RAR与住院死亡率之间存在线性关系。结论:RAR是AECOPD合并RF患者院内死亡的独立危险因素。在我们的患者队列中,RAR水平升高与住院死亡率增加相关。
{"title":"Association between red cell distribution width-to-albumin ratio and In-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: a retrospective cohort study.","authors":"Ruoqing Zhou, Dianzhu Pan","doi":"10.1080/17520363.2025.2548189","DOIUrl":"10.1080/17520363.2025.2548189","url":null,"abstract":"<p><strong>Aims: </strong>This study aimed to investigate the association between the Red cell distribution width-to-albumin ratio (RAR) and in-hospital mortality in patients experiencing Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) with concurrent Respiratory Failure (RF).</p><p><strong>Methods: </strong>This retrospective study included 594 patients diagnosed with AECOPD and RF at the first affiliated hospital of Jinzhou Medical University, China, between January 2021 and September 2023. The primary outcome measure was in-hospital mortality rate. The participants were categorized into three groups according to RAR tertiles: T1 (2.535-3.871), <i>N</i> = 198; T2 (3.88-4.547), <i>N</i> = 196; and T3 (4.56-11.031), <i>N</i> = 200. Logistic regression and subgroup analyses were performed to investigate the relationship between RAR and AECOPD and RF prognosis in patients.</p><p><strong>Results: </strong>The average age of the participants was 72.1 ± 9.7 years, with 52.2% men (<i>n</i> = 310). The mean RAR was 4.3 ± 1.0%/g/dL. After adjusting for covariates, the odds ratio for in-hospital mortality per unit increase in RAR was 1.74 [95% Confidence Interval: 1.19-2.55], <i>p</i> = 0.004. A linear relationship was observed between RAR and in-hospital mortality among patients with AECOPD and RF.</p><p><strong>Conclusion: </strong>RAR is an independent risk factor for in-hospital mortality in patients with AECOPD complicated by RF. Elevated RAR levels were associated with increased in-hospital mortality in our patient cohort.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"717-724"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating cell-free DNA methylation of SEPT9 and SFRP2 into a machine learning model for early diagnosis of HCC. 将SEPT9和SFRP2的游离DNA甲基化整合到HCC早期诊断的机器学习模型中。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-08-04 DOI: 10.1080/17520363.2025.2541574
Dong Wang, Zhihao Dai, Minghua Bai, Dong Liu, Yanru Feng, Quanquan Sun, Tong Zhang, Liang Han, Rui Wang, Ji Zhu, Weifeng Hong, Weiwei Li

Background: Hepatocellular carcinoma (HCC), a primary contributor to cancer-associated mortality, necessitates enhanced early detection. This study evaluated machine learning models that merge methylated SEPTIN9 (SEPT9) and secreted frizzled-related protein 2 (SFRP2) within circulating cell-free DNA (cfDNA) to detect HCC.

Methods: A cohort of 165 healthy volunteers, 24 precancerous patients of HCC and 112 HCC patients were divided into training and validation sets. Methylated SEPT9 and SFRP2 (mSEPT9/mSFRP2) were detected using real-time PCR. Based on those methylation biomarkers and/or conventional biomarkers (CEA, AFP, CA125, and CA19-9), six machine learning algorithms, including Random Forest (RF), were employed to establish models for the training set. Models were evaluated for area under the ROC curve (AUC), sensitivity, and specificity, and subsequently validated in the validation set.

Results: The RF model outperformed other models. In training, it achieved an AUC of 0.834 (95% CI: 0.745-0.923), exhibiting 69.3% sensitivity and 80.6% specificity for the methylation-specific signature group (mSS group: mSEPT9/mSFRP2). In validation, the RF model for the mSS group showed an AUC of 0.865 (95% CI: 0.811-0.946), with 85.4% sensitivity and 71.4% specificity.

Conclusions: The RF-based model integrating mSEPT9/mSFRP2 in cfDNA can be a promising approach for HCC diagnosis.

背景:肝细胞癌(HCC)是癌症相关死亡的主要原因之一,需要加强早期检测。该研究评估了在循环无细胞DNA (cfDNA)中合并甲基化SEPTIN9 (SEPT9)和分泌卷曲相关蛋白2 (SFRP2)的机器学习模型,以检测HCC。方法:将165名健康志愿者、24名肝癌前患者和112名肝癌患者分为训练组和验证组。实时荧光定量PCR检测甲基化的SEPT9和SFRP2 (mSEPT9/mSFRP2)。基于甲基化生物标记物和/或常规生物标记物(CEA、AFP、CA125和CA19-9),采用随机森林(Random Forest, RF)等6种机器学习算法建立训练集模型。评估模型的ROC曲线下面积(AUC)、敏感性和特异性,并随后在验证集中进行验证。结果:RF模型优于其他模型。在训练中,它的AUC为0.834 (95% CI: 0.745-0.923),对甲基化特异性特征组(mSS组:mSEPT9/mSFRP2)的敏感性为69.3%,特异性为80.6%。在验证中,mSS组的RF模型的AUC为0.865 (95% CI: 0.811-0.946),敏感性为85.4%,特异性为71.4%。结论:在cfDNA中整合mSEPT9/mSFRP2的基于rf的模型可能是一种很有前景的HCC诊断方法。
{"title":"Integrating cell-free DNA methylation of SEPT9 and SFRP2 into a machine learning model for early diagnosis of HCC.","authors":"Dong Wang, Zhihao Dai, Minghua Bai, Dong Liu, Yanru Feng, Quanquan Sun, Tong Zhang, Liang Han, Rui Wang, Ji Zhu, Weifeng Hong, Weiwei Li","doi":"10.1080/17520363.2025.2541574","DOIUrl":"10.1080/17520363.2025.2541574","url":null,"abstract":"<p><strong>Background: </strong>Hepatocellular carcinoma (HCC), a primary contributor to cancer-associated mortality, necessitates enhanced early detection. This study evaluated machine learning models that merge methylated SEPTIN9 (SEPT9) and secreted frizzled-related protein 2 (SFRP2) within circulating cell-free DNA (cfDNA) to detect HCC.</p><p><strong>Methods: </strong>A cohort of 165 healthy volunteers, 24 precancerous patients of HCC and 112 HCC patients were divided into training and validation sets. Methylated SEPT9 and SFRP2 (mSEPT9/mSFRP2) were detected using real-time PCR. Based on those methylation biomarkers and/or conventional biomarkers (CEA, AFP, CA125, and CA19-9), six machine learning algorithms, including Random Forest (RF), were employed to establish models for the training set. Models were evaluated for area under the ROC curve (AUC), sensitivity, and specificity, and subsequently validated in the validation set.</p><p><strong>Results: </strong>The RF model outperformed other models. In training, it achieved an AUC of 0.834 (95% CI: 0.745-0.923), exhibiting 69.3% sensitivity and 80.6% specificity for the methylation-specific signature group (mSS group: mSEPT9/mSFRP2). In validation, the RF model for the mSS group showed an AUC of 0.865 (95% CI: 0.811-0.946), with 85.4% sensitivity and 71.4% specificity.</p><p><strong>Conclusions: </strong>The RF-based model integrating mSEPT9/mSFRP2 in cfDNA can be a promising approach for HCC diagnosis.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"737-745"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144774642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shock indices as predictors in blunt trauma patients in the emergency department. 休克指标在急诊科钝性创伤患者中的预测作用。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 DOI: 10.1080/17520363.2025.2542109
Ozan Utku Deveci, Ataman Köse, Çağrı Safa Buyurgan, Akif Yarkaç, Seyran Bozkurt, Cumhur Özcan, Didem Derici Yıldırım

Aims: To evaluate the effectiveness of Shock Index (SI), Modified Shock Index (MSI), and Age Shock Index (Age SI) in predicting blood transfusion need, surgical intervention, hospital outcomes, and injury severity in blunt trauma patients.

Methods: This retrospective study included 267 adult patients admitted with blunt trauma to the emergency department of a tertiary university hospital between 1 December 2018, and 1 December 2019. Patients with isolated hand/foot trauma, isolated traumatic brain injury, isolated spinal injuries, or minor trauma (AIS ≤2) were excluded. SI, MSI, and Age SI were calculated and analyzed.

Results: SI (p < 0.001), Age SI (p = 0.001), and MSI (p < 0.001) were significantly associated with blood transfusion and mortality. SI > 0.933 and MSI > 1.159 showed good predictive accuracy for blood transfusion; Age SI > 30.945 showed moderate accuracy. For mortality, SI > 1.015, MSI > 1.333, and Age SI > 67.065 demonstrated good predictive power (all p < 0.001). SI and MSI correlated moderately with injury severity (p < 0.001), with SI > 0.905 and MSI > 1.181 indicating significant predictive value.

Conclusion: SI, MSI, and Age SI can predict early blood transfusion and mortality in blunt trauma patients. SI and MSI appear more reliable than Age SI, particularly in predicting transfusion need and injury severity.

目的:评价休克指数(SI)、修正休克指数(MSI)和年龄休克指数(Age SI)在预测钝性创伤患者输血需求、手术干预、医院预后和损伤严重程度方面的有效性。方法:本回顾性研究包括2018年12月1日至2019年12月1日在某三级大学医院急诊科收治的267名成年钝性创伤患者。排除孤立性手/足创伤、孤立性创伤性脑损伤、孤立性脊髓损伤或轻微创伤(AIS≤2)的患者。计算并分析SI、MSI和Age SI。结果:SI (p p = 0.001)、MSI (p 0.933、MSI > 1.159)对输血有较好的预测准确性;年龄SI bbbb30 .945为中等准确度。对于死亡率,SI > 1.015、MSI > 1.333、Age SI > 67.065具有较好的预测能力(p均为0.905,MSI > 1.181具有显著的预测价值)。结论:SI、MSI和Age SI可以预测钝性创伤患者的早期输血和死亡率。SI和MSI似乎比Age SI更可靠,特别是在预测输血需求和损伤严重程度方面。
{"title":"Shock indices as predictors in blunt trauma patients in the emergency department.","authors":"Ozan Utku Deveci, Ataman Köse, Çağrı Safa Buyurgan, Akif Yarkaç, Seyran Bozkurt, Cumhur Özcan, Didem Derici Yıldırım","doi":"10.1080/17520363.2025.2542109","DOIUrl":"10.1080/17520363.2025.2542109","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the effectiveness of Shock Index (SI), Modified Shock Index (MSI), and Age Shock Index (Age SI) in predicting blood transfusion need, surgical intervention, hospital outcomes, and injury severity in blunt trauma patients.</p><p><strong>Methods: </strong>This retrospective study included 267 adult patients admitted with blunt trauma to the emergency department of a tertiary university hospital between 1 December 2018, and 1 December 2019. Patients with isolated hand/foot trauma, isolated traumatic brain injury, isolated spinal injuries, or minor trauma (AIS ≤2) were excluded. SI, MSI, and Age SI were calculated and analyzed.</p><p><strong>Results: </strong>SI (<i>p</i> < 0.001), Age SI (<i>p</i> = 0.001), and MSI (<i>p</i> < 0.001) were significantly associated with blood transfusion and mortality. SI > 0.933 and MSI > 1.159 showed good predictive accuracy for blood transfusion; Age SI > 30.945 showed moderate accuracy. For mortality, SI > 1.015, MSI > 1.333, and Age SI > 67.065 demonstrated good predictive power (all <i>p</i> < 0.001). SI and MSI correlated moderately with injury severity (<i>p</i> < 0.001), with SI > 0.905 and MSI > 1.181 indicating significant predictive value.</p><p><strong>Conclusion: </strong>SI, MSI, and Age SI can predict early blood transfusion and mortality in blunt trauma patients. SI and MSI appear more reliable than Age SI, particularly in predicting transfusion need and injury severity.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"747-755"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144764585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum asprosin, ox-LDL, and LOX-1 levels in patients with hypertension and their association with cardiovascular risk. 高血压患者血清asprosin、ox-LDL和LOX-1水平及其与心血管风险的关系
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-07-29 DOI: 10.1080/17520363.2025.2540770
Çağla Özdemir, Hatice Solak

Aim: Our study aimed to investigate the relationship between oxidized low-density lipoprotein(ox-LDL), lectin-like ox-LDL receptor-1 (LOX-1), inducible nitric oxide synthase(iNOS), endothelin 1(ET-1), and asprosin levels with cardiovascular risk.

Method: The study is a case-control study. 177 patients (87 HT/90 controls) were included in the study. Biochemical parameters and blood pressure were measured. Cardiovascular risk was calculated using the European Society of Cardiology Cardiovascular Diseases (ESC CVD) risk calculator. Asprosin, oxLDL, LOX1R, ET1 and iNOS levels were measured using Enzyme-Linked ImmunoSorbent Assay (ELISA) kits in blood samples obtained after a minimum 8-hour fasting period. In statistical analyses, p < 0.05 was considered significant.

Results: Age was significantly higher in the patient group than in the control group(p < .001). Following adjustment for confounding variables, including age, sex, BMI and smoking status, ANCOVA analysis revealed that ET-1 [F(1,177) = 4.002, p = .047, ηp2 = 0.133] and oxLDL [F(1,177) = 17.221, p < .001, ηp2 = 0.262] levels were elevated in the control group relative to the HT group. The correlation analysis revealed a positive correlation between age and cardiovascular risk (p < .001). Furthermore, a negative correlation was identified between cardiovascular risk and ET1 (p < .05), iNOS (p < .001), asprosin (p < .05) and oxLDL ;(p < .001).

Conclusion: ET1 and ox-LDL were lower in the HT group treated with antihypertensive therapy compared to the control group. Moreover, asprosin was found to be low in patients with high cardiovascular risk.

目的:探讨氧化低密度脂蛋白(ox-LDL)、凝集素样ox-LDL受体-1 (LOX-1)、诱导型一氧化氮合酶(iNOS)、内皮素1(ET-1)和阿斯利尿素水平与心血管疾病的关系。方法:本研究为病例对照研究。177例患者(87例HT/90例对照)纳入研究。测量生化指标和血压。使用欧洲心血管病学会(ESC CVD)风险计算器计算心血管风险。禁食至少8小时后,采用酶联免疫吸附试验(ELISA)试剂盒检测血样品中的Asprosin、oxLDL、LOX1R、ET1和iNOS水平。结果:患者组年龄明显高于对照组(p p =。[047, ηp2 = 0.133]和oxLDL [F(1,177) = 17.221, p2 = 0.262]水平均高于HT组。相关分析显示年龄与心血管风险呈正相关(p p p p p p)结论:HT组降压治疗后ET1和ox-LDL低于对照组。此外,asprosin在心血管风险高的患者中含量较低。
{"title":"Serum asprosin, ox-LDL, and LOX-1 levels in patients with hypertension and their association with cardiovascular risk.","authors":"Çağla Özdemir, Hatice Solak","doi":"10.1080/17520363.2025.2540770","DOIUrl":"10.1080/17520363.2025.2540770","url":null,"abstract":"<p><strong>Aim: </strong>Our study aimed to investigate the relationship between oxidized low-density lipoprotein(ox-LDL), lectin-like ox-LDL receptor-1 (LOX-1), inducible nitric oxide synthase(iNOS), endothelin 1(ET-1), and asprosin levels with cardiovascular risk.</p><p><strong>Method: </strong>The study is a case-control study. 177 patients (87 HT/90 controls) were included in the study. Biochemical parameters and blood pressure were measured. Cardiovascular risk was calculated using the European Society of Cardiology Cardiovascular Diseases (ESC CVD) risk calculator. Asprosin, oxLDL, LOX1R, ET1 and iNOS levels were measured using Enzyme-Linked ImmunoSorbent Assay (ELISA) kits in blood samples obtained after a minimum 8-hour fasting period. In statistical analyses, <i>p</i> < 0.05 was considered significant.</p><p><strong>Results: </strong>Age was significantly higher in the patient group than in the control group(<i>p</i> < .001). Following adjustment for confounding variables, including age, sex, BMI and smoking status, ANCOVA analysis revealed that ET-1 [F(1,177) = 4.002, <i>p</i> = .047, ηp<sup>2</sup> = 0.133] and oxLDL [F(1,177) = 17.221, <i>p</i> < .001, ηp<sup>2</sup> = 0.262] levels were elevated in the control group relative to the HT group. The correlation analysis revealed a positive correlation between age and cardiovascular risk (<i>p</i> < .001). Furthermore, a negative correlation was identified between cardiovascular risk and ET1 (<i>p</i> < .05), iNOS (<i>p</i> < .001), asprosin (<i>p</i> < .05) and oxLDL ;(<i>p</i> < .001).</p><p><strong>Conclusion: </strong>ET1 and ox-LDL were lower in the HT group treated with antihypertensive therapy compared to the control group. Moreover, asprosin was found to be low in patients with high cardiovascular risk.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"637-645"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reference intervals for serum albumin, total protein, and prealbumin in healthy children in Nanning, China. 中国南宁健康儿童血清白蛋白、总蛋白和前白蛋白的参考区间。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 DOI: 10.1080/17520363.2025.2539066
Mengli Fan, Liling Yi, Siting Li, Chunling Zhu, Liuyi Lu, Qiliu Peng

Aim: The diagnosis, treatment, and prognosis of childhood diseases rely on accurately establishing reference intervals (RIs). The aim of this study was to determine the RIs of albumin (ALB), total protein (TP), and prealbumin (PA) in children in Nanning, China, according to age, gender, and ethnicity.

Methods: A total of 4001 apparently healthy children aged 0 ~ 18 years from the Nanning area were included. The levels of serum ALB, TP, and PA were measured by an Architect C16000 automatic chemical analyzer. Non-parametric methods were used to determine the 2.5th and 97.5th percentile RIs.

Results: Serum TP and PA levels increased with age (p < 0.001), whereas serum ALB level had no correlation with age (p > 0.05). Gender and ethnicity statistical differences were presented in serum ALB and PA except serum TP. Serum levels of ALB and PA in males were higher than those in females (p < 0.001). Serum ALB and PA showed lower concentrations in Zhuang children as compared to Han children (p < 0.05). All verification groups passed the verification of the RIs.

Conclusions: Age-, gender- and ethnicity-appropriate RIs for serum ALB, TP, and PA will provide a more accurate evaluation of pediatric-related diseases.

目的:儿童疾病的诊断、治疗和预后依赖于准确建立参考区间(RIs)。本研究的目的是根据年龄、性别和种族,确定中国南宁儿童白蛋白(ALB)、总蛋白(TP)和前白蛋白(PA)的RIs。方法:选取南宁地区0 ~ 18岁表面健康儿童4001例。采用Architect C16000全自动化学分析仪测定血清ALB、TP、PA水平。采用非参数方法确定2.5和97.5%的ri。结果:血清TP、PA水平随年龄增长而升高(p < 0.05)。除血清TP外,血清ALB和PA在性别和种族间存在统计学差异。男性血清ALB和PA水平高于女性(p p)结论:与年龄、性别和种族相适应的血清ALB、TP和PA RIs将提供更准确的儿科相关疾病评估。
{"title":"Reference intervals for serum albumin, total protein, and prealbumin in healthy children in Nanning, China.","authors":"Mengli Fan, Liling Yi, Siting Li, Chunling Zhu, Liuyi Lu, Qiliu Peng","doi":"10.1080/17520363.2025.2539066","DOIUrl":"10.1080/17520363.2025.2539066","url":null,"abstract":"<p><strong>Aim: </strong>The diagnosis, treatment, and prognosis of childhood diseases rely on accurately establishing reference intervals (RIs). The aim of this study was to determine the RIs of albumin (ALB), total protein (TP), and prealbumin (PA) in children in Nanning, China, according to age, gender, and ethnicity.</p><p><strong>Methods: </strong>A total of 4001 apparently healthy children aged 0 ~ 18 years from the Nanning area were included. The levels of serum ALB, TP, and PA were measured by an Architect C16000 automatic chemical analyzer. Non-parametric methods were used to determine the 2.5th and 97.5th percentile RIs.</p><p><strong>Results: </strong>Serum TP and PA levels increased with age (<i>p</i> < 0.001), whereas serum ALB level had no correlation with age (<i>p</i> > 0.05). Gender and ethnicity statistical differences were presented in serum ALB and PA except serum TP. Serum levels of ALB and PA in males were higher than those in females (<i>p</i> < 0.001). Serum ALB and PA showed lower concentrations in Zhuang children as compared to Han children (<i>p</i> < 0.05). All verification groups passed the verification of the RIs.</p><p><strong>Conclusions: </strong>Age-, gender- and ethnicity-appropriate RIs for serum ALB, TP, and PA will provide a more accurate evaluation of pediatric-related diseases.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"685-695"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144759139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer. 血浆源性circALG8和circCAMTA1作为非小细胞肺癌早期诊断的指标。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-08-03 DOI: 10.1080/17520363.2025.2542115
Yufei Sheng, Lulu Yang, Boyang Wang, Zhiqi Hong, Jin Guo, Chengwei Zhou, Tao Li, Wentao Hu, Zhaohui Gong

Background: Endogenous circular RNAs (circRNAs) have been implicated in the progression of cancer. This study aims to identify and evaluate the diagnostic efficacy of the newly found circALG8 and circCAMTA1 in patients with non-small cell lung cancer (NSCLC).

Methods: Differentially expressed circRNAs were identified through plasma circRNA sequencing, followed by validation in NSCLC tissues and plasma samples using RT-qPCR. The stability of circALG8 and circCAMTA1 was determined by RNase R and actinomycin D assays. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic performance of these circRNAs in comparison to traditional tumor biomarkers.

Results: Both circALG8 and circCAMTA1 are significantly downregulated in tumor tissues and plasma from NSCLC patients, correlating closely with TNM staging. The two circRNAs are structurally stable circular RNA molecules, demonstrating considerable stability in plasma of NSCLC patients. The combined plasma circALG8 and circCAMTA1 hold the potential to serve as a diagnostic panel for early-stage NSCLC (AUC: 0.8987, p < 0.0001). Importantly, the combination of the plasma circRNA panel enhances the diagnostic efficacy of traditional tumor biomarkers (AUC: 0.9236, p < 0.0001) in early diagnosis of NSCLC.

Conclusion: Plasma-derived circALG8 and circCAMTA1 May function as a diagnostic panel, thereby improving the diagnostic accuracy for early-stage NSCLC.

背景:内源性环状rna (circRNAs)与癌症的进展有关。本研究旨在鉴定和评价新发现的circALG8和circCAMTA1在非小细胞肺癌(NSCLC)患者中的诊断效果。方法:通过血浆circRNA测序鉴定差异表达的circRNA,然后使用RT-qPCR在NSCLC组织和血浆样本中进行验证。通过RNase R和放线菌素D检测circALG8和circCAMTA1的稳定性。与传统肿瘤生物标志物相比,采用受试者工作特征(ROC)曲线分析来评估这些环状rna的诊断性能。结果:circALG8和circCAMTA1在NSCLC患者肿瘤组织和血浆中均显著下调,且与TNM分期密切相关。这两种环状RNA是结构稳定的环状RNA分子,在NSCLC患者血浆中表现出相当大的稳定性。血浆circALG8和circCAMTA1联合检测具有作为早期非小细胞肺癌诊断面板的潜力(AUC: 0.8987, p)。结论:血浆circALG8和circCAMTA1可作为早期非小细胞肺癌的诊断面板,从而提高早期非小细胞肺癌的诊断准确性。
{"title":"Plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer.","authors":"Yufei Sheng, Lulu Yang, Boyang Wang, Zhiqi Hong, Jin Guo, Chengwei Zhou, Tao Li, Wentao Hu, Zhaohui Gong","doi":"10.1080/17520363.2025.2542115","DOIUrl":"10.1080/17520363.2025.2542115","url":null,"abstract":"<p><strong>Background: </strong>Endogenous circular RNAs (circRNAs) have been implicated in the progression of cancer. This study aims to identify and evaluate the diagnostic efficacy of the newly found circALG8 and circCAMTA1 in patients with non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>Differentially expressed circRNAs were identified through plasma circRNA sequencing, followed by validation in NSCLC tissues and plasma samples using RT-qPCR. The stability of circALG8 and circCAMTA1 was determined by RNase R and actinomycin D assays. Receiver operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic performance of these circRNAs in comparison to traditional tumor biomarkers.</p><p><strong>Results: </strong>Both circALG8 and circCAMTA1 are significantly downregulated in tumor tissues and plasma from NSCLC patients, correlating closely with TNM staging. The two circRNAs are structurally stable circular RNA molecules, demonstrating considerable stability in plasma of NSCLC patients. The combined plasma circALG8 and circCAMTA1 hold the potential to serve as a diagnostic panel for early-stage NSCLC (AUC: 0.8987, <i>p</i> < 0.0001). Importantly, the combination of the plasma circRNA panel enhances the diagnostic efficacy of traditional tumor biomarkers (AUC: 0.9236, <i>p</i> < 0.0001) in early diagnosis of NSCLC.</p><p><strong>Conclusion: </strong>Plasma-derived circALG8 and circCAMTA1 May function as a diagnostic panel, thereby improving the diagnostic accuracy for early-stage NSCLC.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"725-736"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144774643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electro-impedimetric detection of human anti-mycolate antibody biomarkers of TB before, during, and after treatment. 治疗前、治疗中、治疗后人抗真菌酸抗体生物标志物的电阻抗检测。
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-09-04 DOI: 10.1080/17520363.2025.2548196
Carl Baumeister, Jan Verschoor, Veronica Ueckermann, Mosa Molatseli, Thoriso Sesing, Nomthandazo Khuboni, Bernard Fourie

Aim: This study assessed electro-impedimetric detection (EIS-MARTI) of anti-mycolate antibodies (AMAb) in TB patients before, during, and after treatment, compared to sputum culture (MGIT) as the gold standard.

Methods: A prospective pilot study enrolled 15 confirmed TB patients and 73 healthy controls at a Pretoria hospital (2016-2017). A prospective monitoring study followed 25 confirmed TB patients over 6 months of treatment at a Pretoria clinic (2019-2020) to evaluate biomarker behavior. Outcomes were analyzed using descriptive statistics, wherein diagnostic accuracy and predictive values were assessed by ROC curve analysis.

Results: EIS-MARTI detected 14/15 true TB-positive cases independent of HIV co-infection and 68/73 true TB-negatives in the pilot study. In the monitoring study, EIS-MARTI correlated with culture in 7/8 cases at treatment end, but not during the first 2 months.

Conclusion: AMAbs arise independently of HIV co-infection in active TB, recede during treatment, and are rapidly detected by a hand-held EIS-MARTI device. While suitability for treatment monitoring remains uncertain, EIS-MARTI shows promise for rapid, accurate TB diagnosis and confirming cure.

目的:本研究评估了电阻抗检测(EIS-MARTI)在结核病患者治疗前,治疗期间和治疗后的抗真菌酸抗体(AMAb),并将痰培养(MGIT)作为金标准。方法:一项前瞻性试点研究(2016-2017)在比勒陀利亚一家医院招募了15名确诊结核病患者和73名健康对照者。一项前瞻性监测研究对比勒陀利亚一家诊所(2019-2020年)25名确诊结核病患者进行了为期6个月的治疗,以评估生物标志物的行为。结果分析采用描述性统计,其中诊断准确性和预测值采用ROC曲线分析。结果:在前期研究中,EIS-MARTI检测出14/15的独立于HIV合并感染的真结核阳性病例和68/73的真结核阴性病例。在监测研究中,7/8的治疗结束时EIS-MARTI与培养相关,但在前2个月没有。结论:在活动性结核病中,AMAbs独立于HIV合并感染而产生,在治疗期间消退,并且可以通过手持式EIS-MARTI设备快速检测到。虽然治疗监测的适用性仍不确定,但EIS-MARTI显示出快速、准确的结核病诊断和确认治愈的希望。
{"title":"Electro-impedimetric detection of human anti-mycolate antibody biomarkers of TB before, during, and after treatment.","authors":"Carl Baumeister, Jan Verschoor, Veronica Ueckermann, Mosa Molatseli, Thoriso Sesing, Nomthandazo Khuboni, Bernard Fourie","doi":"10.1080/17520363.2025.2548196","DOIUrl":"10.1080/17520363.2025.2548196","url":null,"abstract":"<p><strong>Aim: </strong>This study assessed electro-impedimetric detection (EIS-MARTI) of anti-mycolate antibodies (AMAb) in TB patients before, during, and after treatment, compared to sputum culture (MGIT) as the gold standard.</p><p><strong>Methods: </strong>A prospective pilot study enrolled 15 confirmed TB patients and 73 healthy controls at a Pretoria hospital (2016-2017). A prospective monitoring study followed 25 confirmed TB patients over 6 months of treatment at a Pretoria clinic (2019-2020) to evaluate biomarker behavior. Outcomes were analyzed using descriptive statistics, wherein diagnostic accuracy and predictive values were assessed by ROC curve analysis.</p><p><strong>Results: </strong>EIS-MARTI detected 14/15 true TB-positive cases independent of HIV co-infection and 68/73 true TB-negatives in the pilot study. In the monitoring study, EIS-MARTI correlated with culture in 7/8 cases at treatment end, but not during the first 2 months.</p><p><strong>Conclusion: </strong>AMAbs arise independently of HIV co-infection in active TB, recede during treatment, and are rapidly detected by a hand-held EIS-MARTI device. While suitability for treatment monitoring remains uncertain, EIS-MARTI shows promise for rapid, accurate TB diagnosis and confirming cure.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"769-782"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12416203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144990918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-140-5p and cystatin-C expression in patients with vascular cognitive impairment and its clinical value. 血管性认知障碍患者MicroRNA-140-5p和胱抑素- c的表达及其临床价值
IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-08-01 Epub Date: 2025-05-22 DOI: 10.1080/17520363.2025.2468150
Huiyan Ding, Yufu Han

Background: Vascular cognitive impairment (VCI) is a cerebrovascular disease leading to mental decline. Appropriate biomarkers must be identified to facilitate the diagnosis of VCI. Therefore, we investigated changes in miR-140-5p and cystatin-C (Cys-C) expression in the serum of patients with VCI.

Methods: The miR-140-5p or Cys-C serum expression levels were determined using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) or immunoturbidimetry. MMP-9 and IL-6 expression were detected in both groups. Correlations between serum-exhaled miR-140-5p or Cys-C and IL-6 or MMP-9 were analyzed using Pearson's method. A receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of miR-140-5p, Cys-C, and miR-140-5p combined with Cys-C for diagnosing VCI.

Results: miR-140-5p and Cys-C serum levels were significantly upregulated in patients with VCI, and the increase was more pronounced in patients with vascular dementia (VaD). In addition, miR-140-5p and Cys-C positively correlated with increased IL-6 and MMP-9 expression. The ROC analysis showed that the combination of miR-140-5p and Cys-C demonstrated the AUC was 100.0% (sensitivity: 100%; specificity, 98.3%).

Conclusion: The upregulation of miR-140-5p and Cys-C indicates that miR-140-5p and Cys-C may be related VCI development. The combined diagnosis of miR-140-5p has potential diagnostic value for diagnosis and screening of VCI.

背景:血管性认知障碍(VCI)是一种导致智力下降的脑血管疾病。必须确定适当的生物标志物以促进VCI的诊断。因此,我们研究了VCI患者血清中miR-140-5p和胱抑素- c (cyys - c)表达的变化。方法:采用实时定量逆转录聚合酶链式反应(qRT-PCR)或免疫比浊法检测miR-140-5p或Cys-C血清表达水平。两组均检测MMP-9、IL-6的表达。采用Pearson方法分析血清呼出miR-140-5p或Cys-C与IL-6或MMP-9的相关性。采用受试者工作特征(ROC)曲线评价miR-140-5p、Cys-C以及miR-140-5p联合Cys-C对VCI的诊断价值。结果:miR-140-5p和Cys-C血清水平在VCI患者中显著上调,且在血管性痴呆(VaD)患者中升高更为明显。此外,miR-140-5p和Cys-C与IL-6和MMP-9表达升高呈正相关。ROC分析显示,miR-140-5p与Cys-C联合使用显示AUC为100.0%(灵敏度:100%;特异性,98.3%)。结论:miR-140-5p和Cys-C的上调提示miR-140-5p和Cys-C可能与VCI的发展有关。联合诊断miR-140-5p对VCI的诊断和筛查具有潜在的诊断价值。
{"title":"MicroRNA-140-5p and cystatin-C expression in patients with vascular cognitive impairment and its clinical value.","authors":"Huiyan Ding, Yufu Han","doi":"10.1080/17520363.2025.2468150","DOIUrl":"10.1080/17520363.2025.2468150","url":null,"abstract":"<p><strong>Background: </strong>Vascular cognitive impairment (VCI) is a cerebrovascular disease leading to mental decline. Appropriate biomarkers must be identified to facilitate the diagnosis of VCI. Therefore, we investigated changes in miR-140-5p and cystatin-C (Cys-C) expression in the serum of patients with VCI.</p><p><strong>Methods: </strong>The miR-140-5p or Cys-C serum expression levels were determined using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) or immunoturbidimetry. MMP-9 and IL-6 expression were detected in both groups. Correlations between serum-exhaled miR-140-5p or Cys-C and IL-6 or MMP-9 were analyzed using Pearson's method. A receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of miR-140-5p, Cys-C, and miR-140-5p combined with Cys-C for diagnosing VCI.</p><p><strong>Results: </strong>miR-140-5p and Cys-C serum levels were significantly upregulated in patients with VCI, and the increase was more pronounced in patients with vascular dementia (VaD). In addition, miR-140-5p and Cys-C positively correlated with increased IL-6 and MMP-9 expression. The ROC analysis showed that the combination of miR-140-5p and Cys-C demonstrated the AUC was 100.0% (sensitivity: 100%; specificity, 98.3%).</p><p><strong>Conclusion: </strong>The upregulation of miR-140-5p and Cys-C indicates that miR-140-5p and Cys-C may be related VCI development. The combined diagnosis of miR-140-5p has potential diagnostic value for diagnosis and screening of VCI.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"677-684"},"PeriodicalIF":2.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144118906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomarkers in medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1